Apostle
Innovative solutions for cfDNA/cfRNA isolation, lab consumables, and automation. The company specializes in developing and providing cutting-edge technologies and products for liquid biopsy, genomics, and molecular diagnostics. They offer a comprehensive range of reagents, kits, lab consumables, and instruments designed to improve the efficiency and accuracy of nucleic acid extraction and analysis. The company…
Funding snapshot
About
Innovative solutions for cfDNA/cfRNA isolation, lab consumables, and automation. The company specializes in developing and providing cutting-edge technologies and products for liquid biopsy, genomics, and molecular diagnostics. They offer a comprehensive range of reagents, kits, lab consumables, and instruments designed to improve the efficiency and accuracy of nucleic acid extraction and analysis. The company operates in Life Sciences > Genomics, Life Sciences > Life Sciences Platforms and Tools, High Tech > Nanotechnology, Life Sciences > Oncology. Its business models include Nanotechnology > Nanoenabled Products > Life Science > Diagnostic, Oncology > In-Vitro Diagnostic Tests > Diversified, Genomics > Enabling Technologies > Kits and Reagents > NGS Reagents, Life Scie. Founded in 2017. Headquartered in United States, Sunnyvale. The company has raised funding at the Series A stage. Backed by investors including Amino Capital, ShangBay Capital, Westlake Ventures.
Business model
Nanotechnology > Nanoenabled Products > Life Science > Diagnostic,
Oncology > In-Vitro Diagnostic Tests > Diversified,
Genomics > Enabling Technologies > Kits and Reagents > NGS Reagents,
Life Sciences Platforms and Tools > Research Reagents and Kits > Genomics > NGS Reagents
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.